Product image of Lanso Tad (Lansoprazole) supplied by GNH India

Lanso Tad

Active Ingredient:
Lansoprazole
Origin:
EU

Lanso Tad (Lansoprazole)

Lansoprazole, the active ingredient in Lanso Tad, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid secretion and is used to treat gastro‑esophageal reflux disease, peptic ulcer disease, Helicobacter pylori infection and erosive esophagitis in adults.
GNH India supplies Lanso Tad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Tad Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lansoprazole, a proton pump inhibitor, reduces gastric acid production and is used in several acid‑related gastrointestinal conditions.

  • Gastroesophageal reflux disease (GERD): alleviates heartburn and regurgitation by decreasing acid exposure.
  • Peptic ulcer disease: promotes ulcer healing by suppressing gastric acid secretion.
  • Helicobacter pylori eradication: enhances antibiotic efficacy as part of combination therapy.
  • Erosive esophagitis: heals esophageal mucosal damage by limiting acid reflux.

How It Works

  • Lansoprazole selectively and irreversibly inhibits the H+/K+ ATPase enzyme (the gastric proton pump) located on the secretory surface of gastric parietal cells. By blocking this final step of acid production, it markedly reduces both basal and stimulated gastric acid secretion, leading to increased gastric pH and facilitating healing of acid‑related lesions.

Side Effects

Lansoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Headache: mild to moderate pain often transient.
  • Diarrhea: loose stools, usually self‑limiting.
  • Nausea: feeling of unease or upset stomach.
  • Abdominal pain: discomfort in the upper abdomen.
  • Flatulence: increased intestinal gas.
  • Constipation: reduced bowel movements.

Serious or Rare Side Effects

  • Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome): require immediate medical attention.
  • Clostridioides difficile infection: persistent diarrhea with possible colitis.
  • Hypomagnesemia: low magnesium levels causing muscle cramps or arrhythmias.
  • Elevated liver enzymes: possible hepatic injury.
  • Interstitial nephritis: inflammation of kidney tissue.
  • Increased risk of bone fractures: especially with long‑term use.

Precautions & Warnings

Before initiating therapy with Lansoprazole, consider the following precautions.

  • Renal function assessment: adjust use in patients with severe renal impairment.
  • Magnesium monitoring: check serum magnesium during prolonged treatment.
  • CYP2C19 metabolism: genetic variations may affect drug levels.
  • Elderly patients: use the lowest effective dose and monitor for fractures.
  • Discontinuation: avoid abrupt stopping after long‑term use to prevent rebound acid hypersecretion.
  • Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Lansoprazole may interact with several medications; awareness of the interaction level is essential.

Major Interactions (Avoid)

  • Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk.
  • Atazanavir: decreased absorption, leading to subtherapeutic antiviral levels.
  • Methotrexate: increased toxicity due to reduced renal clearance.

Moderate Interactions (Monitor Closely)

  • Digoxin: higher serum concentrations may occur; monitor levels.
  • Phenytoin: decreased phenytoin levels; adjust dosage as needed.

Frequently Asked Questions

Lanso Tad contains lansoprazole, a proton pump inhibitor indicated for the treatment of gastro‑esophageal reflux disease (GERD), peptic ulcer disease, Helicobacter pylori eradication regimens, and erosive esophagitis. It works by reducing gastric acid secretion, helping to relieve symptoms and promote healing of acid‑related lesions.

Lansoprazole selectively and irreversibly blocks the H+/K+ ATPase pump on gastric parietal cells, which is the final step in acid production. By inhibiting this proton pump, it markedly lowers both basal and stimulated gastric acid output, raising gastric pH and allowing damaged mucosa to heal.

The appropriate dose of Lanso Tad is determined by the prescribing healthcare professional based on the specific indication, patient age, renal function, and other clinical factors. Patients should follow the prescriber’s instructions and not alter the dose without medical guidance.

Safety data for lansoprazole in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers will evaluate individual circumstances before prescribing to pregnant or nursing women.

To order Lanso Tad, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Lansoprazole belongs to the proton pump inhibitor class, which provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, its efficacy is similar, but individual response and drug‑interaction profiles may differ, influencing the choice of therapy.

Lanso Tad should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Maintaining these conditions helps preserve the tablet’s stability and potency throughout its shelf life.

Lanso Tad is taken orally, usually as a whole tablet swallowed with a glass of water. It is generally recommended to take the medication before a meal, but patients should follow the specific instructions provided by their prescriber.

Serious risks include severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome, Clostridioides difficile‑associated diarrhea, low magnesium levels (hypomagnesemia), and rare cases of interstitial nephritis or liver injury. Patients should seek immediate medical attention if they experience symptoms of these conditions.

Lanso Tad should be avoided in individuals with known hypersensitivity to lansoprazole or any component of the formulation. Caution is also advised for patients with severe liver disease, those taking medications that have major interactions, and patients who have experienced previous adverse reactions to proton pump inhibitors.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lansoprazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT